StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
INSYS Therapeutics (INSY) PT Lowered to $7 at RBC Capital
March 8, 2019 6:29 AM
RBC Capital analyst Randall Stanicky ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Insys Therapeutics (INSY) Misses Q4 EPS by 8c
March 7, 2019 4:26 PM
INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results
March 7, 2019 4:15 PM